Skip to main content
. 2023 Oct 5;26(4):390–396. doi: 10.5397/cise.2023.00346

Table 2.

Pre-injection vs. final follow-up in 13 weeks: intragroup analysis

Variable Pre-injection (n=24) Final follow-up (n=24) P-value*
GH group (n=24)
 FE ROM (°) 127.5±7.4 148.8±3.4 <0.001
 ER at side ROM (°) 53.8±13.1 76.9±13.0 <0.001
 IR at 90° ROM (°) 45.4±7.2 75.0±11.5 <0.001
 pVAS score 6.3±2.0 2.6±2.1 <0.001
 ASES score 46.1±18.4 74.5±19.0 <0.001
 Constant score 55.9±7.9 67.2±8.8 <0.001
SA group (n=24)
 FE ROM (°) 129.2±8.3 148.3±3.8 <0.001
 ER at side ROM (°) 54.6±10.8 76.5±8.0 <0.001
 IR at 90° ROM (°) 48.8±9.0 74.4±8.9 <0.001
 pVAS score 6.0±1.2 2.6±1.5 <0.001
 ASES score 53.0±8.9 77.1±12.9 <0.001
 Constant score 59.2±7.6 68.7±9.9 <0.001

Values are presented as mean±standard deviation. GH group: ultrasound-guided glenohumeral steroid injection, SA group: ultrasound-guided subacromial steroid injection.

FE: forward elevation, ROM: range of motion, ER: external rotation at side, IR: internal rotation at 90˚ of abduction, pVAS: pain visual analog scale, ASES: American Shoulder and Elbow Surgeons, Constant: Constant-Murley.

*

P-value <0.05.